Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial Read more about Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children Read more about A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
Frequency of SARS COVID-19 Infection Among Malignant Patients at South Egypt Cancer Institute Read more about Frequency of SARS COVID-19 Infection Among Malignant Patients at South Egypt Cancer Institute
A Study of Baricitinib (LY3009104) in Children With COVID-19 Read more about A Study of Baricitinib (LY3009104) in Children With COVID-19
NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19 Read more about NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19
Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3 Read more about Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3
Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON) Read more about Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)
Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B) Read more about Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)
Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19 Read more about Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19
Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study. Read more about Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.
